COLONOSCOPY BOWEL PREPARATION DRUGS MARKET ANALYSIS

Market Challenges And Opportunities

Global Colonoscopy Bowel Preparation Drugs Market- Driver

Increasing incidence of colorectal cancer

Colorectal cancer is one of the most common cancers worldwide. Regular colonoscopy screenings are essential for early detection and prevention. For instance, according to the World Health Organization report in September 2022, globally, it was projected that there were more than 1.9 million new instances of colorectal cancer and more than 930,000 deaths from the disease in 2020. According to WHO estimates, by 2040, there would be 3.2 million new cases of colorectal cancer annually (an increase of 63%) and 1.6 million annual deaths (an increase of 73%). This drives the demand for colonoscopy bowel preparation drugs as they are necessary to cleanse the colon before the procedure.

Growing awareness and emphasis on preventive healthcare

There has been a significant increase in public awareness about the importance of preventive healthcare measures, including regular screenings such as colonoscopies. This has led to a higher demand for colonoscopy procedures, thereby driving the market for bowel preparation drugs.  For instance, in March 2022, World Health Organization created Colorectal Cancer Awareness Month 2022 in March to promote healthy lifestyle habits that can decrease a person’s risk of developing cancer of the colon, rectum, or anus – the three distinct cancer types referred to collectively as colorectal cancer.

Global Colonoscopy Bowel Preparation Drugs Market: Restraint

Patient compliance and tolerability                

Bowel preparation for colonoscopy typically involves consuming a large volume of laxatives or solutions, which can be challenging for some patients. The taste, texture, and quantity of the preparation can lead to poor patient compliance and tolerability. Patients may find the process unpleasant and may be reluctant to undergo colonoscopy screenings, thus impacting the demand for bowel preparation drugs.

Side effects and safety concerns

Bowel preparation drugs can cause side effects such as bloating, abdominal discomfort, nausea, vomiting, and electrolyte imbalances. These side effects may deter patients from completing the bowel preparation regimen or may pose risks for individuals with certain medical conditions. Safety concerns associated with bowel preparation drugs may also lead to hesitancy or caution among healthcare providers and patients.

Global Colonoscopy Bowel Preparation Drugs Market: Key Players

Major players operating in the global colonoscopy bowel preparation drugs market include Ferring B.V., Bayer AG, Braintree, Bausch Health Companies Inc., and Norgine B.V.